The Involvement of Akt Activation in Erythropoietin Induced Neuroprotection in Rat Model of Parkinson’s Disease

Chen QI,Jing GAN,Na WU,Lu SONG,Wei-en YUAN,Zhen-guo LIU
2014-01-01
Abstract:Aim To investigate the neuroprotection of erythropoietin in a rat model of Parkinson’s disease (PD) and explore the mechanisms underlying these effects. Methods The rats were divided into three groups. The rats model of PD were induced by stereotactic injection of 6-OHDA.EPO (10 000 U·kg-1·d-1) was continuously administered intraperitoneal injection for a week to the rats before 6-OHDA injection. The sham operation group stereotactic injected of saline. Neurobehavior in rats were measured in 3 weeks after the treatments.Survival of substantia nigra (SN) dopaminergic neurons, tyrosine hydroxylase (TH) levels and EPO-R levels and phosphoprotein of serine-threonine kinase(Akt) at serine 473 levels were determined by immunohistochemistry and Western blot respectively. Results There was a significant increase in EPO levels in the CSF after EPO administered. Neurobehavior was signiifcantly improved in the rats that were pretreated with EPO compared with PD rats. The dopaminergic neurons in SN were also increased in the EPO pretreated rats when compared with the PD rats. Western blot analysis showed that EPO-R and phosphorylated Akt Ser473 in SN were increased significantly compared with PD and sham rats (P﹤0.05). Conclusion These findings suggested that EPO exerted neuroprotective effects in reversing behavioral deifcits may be associated with PD through the Akt pathway.
What problem does this paper attempt to address?